Our experimental data showed alterations in DNM3OS expression were linked to EMT in ovarian cancer through changes in cell migration and invasion and EMT-linked RNA and protein levels, and ovarian cancer patient survival. Here, DNM3OS is linked to ovarian carcinoma.